GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
12.0251 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.0692 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FLT3, HCAR2, HTR2A, HTR2B, HTR6, KDR, MET, MMP9, SRC, TNKS, TNKS2, XDH |
8.98098 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FLT3, HCAR2, HTR2A, HTR2B, HTR6, KDR, MET, MMP9, SRC, TNKS, TNKS2, XDH |
8.98098 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FABP3, FABP4, FLT3, HCAR2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR7, KDR, MET, PPARA, SRC, TNKS, TNKS2, XDH |
8.43253 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
8.14557 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TYR |
8.14557 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
7.98471 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALOX15, ALOX5, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, HTR2B, PIM1, PPARA, TYR, XDH |
7.98471 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, ADRA1A, AKR1B1, ALOX15, ALPL, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, FABP3, FABP4, FLT3, HSD17B2, HTR2A, HTR2B, HTR5A, IGF1R, KDR, MMP2, MMP9, PPARA, RORC, SRC, TYR |
7.50009 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
7.50009 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
7.24426 |
[BP] GO:0007210 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.99848 |
[BP] GO:0098664 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.99848 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALOX5, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD2, FABP3, FABP4, HSD17B1, HSD17B2, MET, PPARA |
6.99198 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
6.85681 |
[BP] GO:0010033 |
response to organic substance
|
ADRA1A, AKR1B1, ALOX15, ALPL, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, FABP3, FABP4, FLT3, HSD17B2, HTR5A, IGF1R, KDR, MMP2, PPARA, RORC, SRC, TYR |
6.8057 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, DRD1, DRD2, DRD3, HCAR2, HTR2A, HTR2B, KDR, SRC, TNKS, TNKS2 |
6.63832 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, FABP3, HSD17B2, HTR5A, IGF1R, MMP2, MMP9, PPARA, RORC, SRC, TYR |
6.60967 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
6.15607 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, F10, F3, FLT3, HTR2A, HTR2B, HTR6, KDR, MET, MMP9, SRC, TNKS, TNKS2, XDH |
6.15607 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, HTR2B, KDR, SRC |
6.11759 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
6.01941 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP9, PTPRS, SRC, TNKS, TNKS2, XDH |
5.92313 |
[BP] GO:0097756 |
None
|
ADORA1, ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
5.87591 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, PPARA |
5.86122 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP9, PTPRS, SRC, TNKS, TNKS2, XDH |
5.82187 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.82187 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.82187 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA1A, AKR1B1, ALOX15, ALOX5, ALPL, AXL, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FABP4, HSD17B2, HTR1A, HTR2A, HTR2B, HTR7, IGF1R, MET, MMP1, MMP2, MMP9, PIM1, PPARA, RORC, SRC, TNKS2, TYR |
5.72373 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.6026 |
[BP] GO:0007187 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR6, HTR7 |
5.49173 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, FLT3, HTR5A, RORC, SRC, TYR |
5.42528 |
[BP] GO:0006939 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
5.40926 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AXL, CYP1B1, DRD2, F10, F3, FLT3, HTR2A, HTR2B, HTR6, KDR, MET, SRC, XDH |
5.39178 |
[BP] GO:0042493 |
response to drug
|
ABCB1, ADRA1A, AKR1B1, AXL, CA9, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, FABP3, HTR2A, HTR2B, KDR, SRC |
5.37322 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FABP3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, RORC, SRC, TNKS, TNKS2, XDH |
5.21818 |
[BP] GO:0006811 |
None
|
ABCB1, ADRA1A, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, DRD3, FABP3, HTR2A, HTR2B, PPARA |
5.13084 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, DRD3, FABP3, FLT3, HCAR2, HTR2A, HTR2B, PPARA, RORC, SRC |
5.09255 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, AKR1B1, CSNK2A1, CYP1B1, DRD2, DRD3, F3, FABP3, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MMP2, MMP9, PIM1, SRC, XDH |
5.02717 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MMP9, SRC |
5.02717 |
[BP] GO:0042310 |
None
|
ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
4.96732 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FABP3, FABP4, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, RORC, SRC, TNKS, TNKS2, XDH |
4.96732 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, F10, F3, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP9, SRC, XDH |
4.95657 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7, SRC |
4.92805 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, F10, F3, FABP4, FLT3, HTR2A, HTR2B, HTR6, KDR, MET, MMP2, MMP9, SRC, TNKS, TNKS2, XDH |
4.92805 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
4.91686 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, DRD3, HCAR2, TNKS, TNKS2 |
4.84434 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, ADRA1A, CA2, CA7, DRD2 |
4.7853 |
[BP] GO:0050795 |
None
|
ADORA1, DRD2, DRD3, HTR1A, HTR2A, HTR2B |
4.76946 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD2, FABP3, FABP4, MET, PPARA |
4.75871 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, FABP3, FLT3, HSD17B2, HTR5A, RORC, SRC, TYR |
4.71709 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, ALPL, AURKB, AXL, CA2, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, FABP4, FLT3, HSD17B2, HTR2A, HTR2B, HTR5A, KDR, MET, MMP2, MMP9, PIM1, PPARA, PTPRS, RORC, SIGMAR1, SRC, TNKS2, TYR |
4.67164 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA1, ADORA3, ALOX15, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, HCAR2, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MET, MMP9, PPARA, SRC |
4.67087 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, DRD2, HCAR2, HSD17B1, HSD17B2, HTR1A, HTR2A |
4.66146 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, F10, F3, FABP3, FABP4, FLT3, HSD17B1, HSD17B2, HTR1A, HTR2B, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPRS, RORC, SRC, TNKS, TNKS2, TYR, XDH |
4.59712 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, HSD17B1, HSD17B2 |
4.57253 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALOX15, ALPL, AURKB, AXL, CA2, CA6, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FABP3, FABP4, FLT3, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, IGF1R, KDR, MMP2, MMP9, PPARA, RORC, SRC, TYR |
4.53282 |
[BP] GO:0007198 |
None
|
HTR1A, HTR5A, HTR7 |
4.51201 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HSD17B1, HSD17B2, TYR, XDH |
4.42643 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
4.42643 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
4.42643 |
[BP] GO:0007193 |
None
|
ADORA1, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
4.39646 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, ALOX15, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, F10, FABP3, FABP4, FLT3, HSD17B1, HSD17B2, HTR1A, HTR2B, IGF1R, KDR, MET, MMP1, MMP2, PIM1, PPARA, PTPRS, RORC, SRC, TNKS, TNKS2, TYR, XDH |
4.34493 |
[BP] GO:0018958 |
None
|
AKR1B1, DRD1, DRD2, DRD3, HTR1A, TYR |
4.33705 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
4.26173 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
4.24345 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, SRC |
4.22204 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7, SRC |
4.12731 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, PPARA |
4.05813 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, F10, F3, MET, SRC, XDH |
4.04 |
[BP] GO:0032845 |
None
|
ADORA1, DRD2, HTR2A, HTR2B, SRC, TNKS, TNKS2 |
4.02866 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3, HTR2A |
4.0074 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA1A, AKR1B1, ALPL, CA2, CA9, CSNK2A1, CYP1A2, DRD1, FABP3, FLT3, HTR5A, IGF1R, MMP2, PPARA, SRC |
3.96484 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, HTR2A |
3.93453 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, HTR2A |
3.93453 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, KDR, SRC |
3.85406 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, F3, FLT3, HCAR2, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PPARA, SIGMAR1, SRC, XDH |
3.79874 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, CSNK2A1, DRD2, DRD3, F3, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MMP2, MMP9, PIM1 |
3.77222 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, ALOX15, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, HTR1A, TYR |
3.75276 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, IGF1R, KDR, MET, MMP9, SRC |
3.74456 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.71099 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, DRD1, DRD2, DRD3 |
3.69805 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, MET, MMP9, SRC |
3.67209 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, ALPL, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, FLT3, HSD17B2, HTR5A, KDR, MMP9, PIM1, PPARA, PTPRS, RORC, SIGMAR1, SRC, TYR |
3.66699 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, ADORA1, ADRA1A, AKR1B1, ALOX15, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FABP4, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP2, MMP9, PPARA, PTPRS, SRC, TNKS, TNKS2, XDH |
3.66433 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, F3, FLT3, HCAR2, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, SIGMAR1, SRC, XDH |
3.63649 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA1A, AKR1B1, AXL, CA12, CA2, CA7, DRD1, DRD2, DRD3, FABP3, FABP4, FLT3, HTR2A, HTR2B, MET, SRC |
3.63095 |
[BP] GO:0009725 |
response to hormone
|
ADRA1A, AKR1B1, ALPL, CA2, CA9, CSNK2A1, CYP1A2, FABP3, FLT3, HTR5A, PPARA, SRC |
3.60952 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
3.59783 |
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3 |
3.50911 |
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3 |
3.50911 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6, RORC |
3.47652 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2, HTR2A |
3.45294 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, CSNK2A1, DRD1, DRD2, DRD3, HTR1A |
3.43961 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, MET, MMP9, SRC |
3.41072 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, HTR2A, MET |
3.40172 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
3.40172 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B |
3.35905 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALOX15, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, F10, F3, FABP3, FABP4, FLT3, HCAR2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPRS, RORC, SIGMAR1, SRC, TNKS, TNKS2, TUBB3, TYR, XDH |
3.35206 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2 |
3.3503 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2, HTR2A |
3.31802 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, PPARA, SRC |
3.31486 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, ADRA1A, CA2, DRD1, DRD2, DRD3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1, SRC |
3.30819 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.25655 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ADRA1A, ALOX15, DRD2, HTR2A, HTR2B, KDR, SRC |
3.24616 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, PIM1, PPARA, TYR |
3.24477 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, SRC |
3.24477 |
[BP] GO:0006810 |
None
|
ABCB1, ACHE, ADORA1, ADRA1A, ALOX15, ALOX5, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, DRD3, F10, FABP3, HTR2A, HTR2B, MMP9, PPARA, SIGMAR1, SRC, TNKS, XDH |
3.24477 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7 |
3.24397 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.24397 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, AURKB, CA2, CYP1A1, DRD1, DRD2, DRD3, HTR2A, HTR2B, MMP2, PPARA, SRC, TYR |
3.24397 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, DRD2, DRD3, HTR7, PPARA, RORC, SRC |
3.22799 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CSNK2A1, CYP1B1, CYP2D6, DRD2, DRD3, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, SRC, TNKS |
3.18565 |
[BP] GO:0051952 |
None
|
ADORA1, DRD1, DRD2, DRD3, HTR2A |
3.14607 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, HTR6 |
3.14363 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, F3, FLT3, HCAR2, HTR2B, IGF1R, KDR, MMP9, PIM1, SIGMAR1, SRC, XDH |
3.13019 |
[BP] GO:0002031 |
None
|
DRD2, DRD3, HTR2B |
3.12475 |
[BP] GO:0048513 |
animal organ development
|
ACHE, ADRA1A, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, FLT3, HSD17B2, KDR, PPARA, PTPRS, SRC, TYR |
3.10965 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, MET, MMP9, SRC |
3.09063 |
[BP] GO:0051179 |
None
|
ABCB1, ACHE, ADORA1, ADRA1A, ALOX15, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, DRD3, F10, FABP3, HTR2A, HTR2B, MMP9, PPARA, SIGMAR1, SRC, TNKS, TNKS2, XDH |
3.081 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA1A, ALOX15, DRD2, FLT3, HTR2A, HTR2B, KDR, SRC, XDH |
3.07683 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA1A, AKR1B1, AXL, CA1, CA2, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, MMP9, PIM1, PPARA, RORC, SIGMAR1, SRC, TNKS, TNKS2 |
3.05401 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, F10, F3, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP9, PTPRS, SRC, TNKS, TNKS2, XDH |
3.01888 |
[BP] GO:0051234 |
None
|
ABCB1, ACHE, ADORA1, ADRA1A, ALOX15, ALOX5, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, DRD3, F10, FABP3, HTR2A, HTR2B, MMP9, PPARA, SIGMAR1, SRC, TNKS, XDH |
2.92126 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.92126 |
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3 |
2.92126 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADRA1A, CA2, CA7 |
2.92126 |
[BP] GO:0007200 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B |
2.90105 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA1A, AKR1B1, CA12, CA2, CA7, DRD1, DRD2, DRD3, FABP3, FABP4, HTR2A, HTR2B, MET |
2.86968 |
[BP] GO:0045776 |
None
|
ADORA1, DRD2, DRD3, PPARA |
2.86968 |
[BP] GO:2001023 |
None
|
DRD1, DRD2, DRD3, HTR2A, MET |
2.86244 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, PIM1, PPARA, TYR |
2.85517 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PPARA, SRC |
2.84388 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.84388 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.84388 |
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3 |
2.84388 |
[BP] GO:0051967 |
None
|
ADORA1, DRD2, HTR2A |
2.84388 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRA1A, DRD1, DRD2, DRD3, HTR2B, HTR5A, KDR |
2.84179 |
[BP] GO:0019933 |
None
|
ADRA1A, DRD1, DRD2, DRD3, HTR5A |
2.83407 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, PIM1, PPARA, TYR |
2.79191 |
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3 |
2.75719 |
[BP] GO:0071702 |
None
|
ABCB1, ADORA1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, DRD3, FABP3, PPARA, SIGMAR1, TNKS |
2.71648 |
[BP] GO:0042752 |
None
|
ADORA1, DRD2, DRD3, PPARA, RORC |
2.68645 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B |
2.67704 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3 |
2.67704 |
[BP] GO:0019935 |
None
|
ADRA1A, DRD1, DRD2, DRD3, HTR5A |
2.6526 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, ALPL, AXL, CYP1A1, CYP1A2, CYP1B1, DRD1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, RORC, SRC |
2.6526 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA1A, ALOX15, DRD2, FLT3, HTR2A, HTR2B, IGF1R, KDR, SRC, XDH |
2.62319 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ADORA1, ALOX15, AXL, CA2, CA7, CYP19A1, DRD1, DRD2, DRD3, HCAR2, HTR1A, HTR2A, HTR2B, MMP9, PPARA, SRC |
2.61032 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.60474 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, SRC |
2.57265 |
[BP] GO:0003012 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
2.54748 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR2B |
2.53306 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, CYP1A1, DRD2, PPARA |
2.52509 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.52036 |
[BP] GO:0090066 |
None
|
ADORA1, ADRA1A, ALOX15, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
2.51916 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.51268 |
[BP] GO:0043269 |
regulation of ion transport
|
ABCB1, ADORA1, CA2, CA7, DRD1, DRD2, DRD3, HTR1A, HTR2A, MMP9 |
2.51116 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.47829 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.47829 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.47829 |
[BP] GO:0031623 |
None
|
ACHE, DRD2, DRD3, HTR2B |
2.47496 |
[BP] GO:0032922 |
None
|
DRD2, DRD3, PPARA, RORC |
2.47496 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ADRA1A, ALOX15, DRD2, HTR2A, HTR2B, KDR, SRC |
2.47149 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.45637 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA1A, ALOX15, DRD1, DRD2, DRD3, FABP3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MMP9, PPARA, SRC, XDH |
2.44382 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, ALPL, AXL, CYP1A1, CYP1B1, DRD1, FABP4, FLT3, IGF1R, KDR, MMP2, RORC, SRC |
2.44091 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, HCAR2, HTR2B, SRC |
2.43893 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, DRD1, DRD2, DRD3, FABP3, FLT3, IGF1R, MMP2, PPARA, SRC, TYR |
2.43757 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, PPARA, PTPRS |
2.43459 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.43459 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.43459 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, ALOX15, DRD1, DRD2, DRD3, FABP3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MMP9, PPARA, SRC, XDH |
2.41709 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, HTR2A |
2.37957 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.37442 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALOX15, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, FABP3, FABP4, HCAR2, HTR2A, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPRS, RORC, SRC, TNKS, TNKS2, XDH |
2.36873 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, AURKB, AXL, CSNK2A1, DRD1, DRD2, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, PTPRS, SRC, TNKS, XDH |
2.35974 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.35827 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, FABP3, FABP4, HTR2A, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPRS, RORC, SRC, TNKS, TNKS2, XDH |
2.35066 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, F3, FABP4, KDR, MET, PPARA, PTPRS |
2.34591 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.33735 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, CSNK2A1, DRD1, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, SRC, TNKS |
2.32374 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, AURKB, CYP1A1, FLT3, HTR1A, MET, PIM1, SRC, TYR |
2.30092 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, ALOX15, DRD1, DRD2, FABP3, FLT3, HTR2A, HTR2B, KDR, MMP9, SRC, XDH |
2.29106 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA1A, ALOX15, DRD1, DRD2, FABP3, FLT3, HTR2A, HTR2B, KDR, MMP9, SRC, XDH |
2.29106 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.27619 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.27619 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.26964 |
[BP] GO:0060402 |
None
|
ADRA1A, DRD2, HTR2A, HTR2B |
2.26964 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.24298 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.24298 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.24298 |
[BP] GO:0050801 |
ion homeostasis
|
ADRA1A, CA12, CA2, CA7, DRD1, DRD2, DRD3, FABP3, HTR2A, HTR2B |
2.23669 |
[BP] GO:0007202 |
None
|
ADRA1A, HTR2A, HTR2B |
2.23341 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.23341 |
[BP] GO:0051050 |
positive regulation of transport
|
ABCB1, ACHE, ADORA1, AXL, CA2, CYP19A1, DRD1, DRD2, DRD3, HCAR2, HTR2B, SRC |
2.23021 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, FABP4, MMP1, MMP2, MMP9, SRC, XDH |
2.21217 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, FABP3, PPARA |
2.20719 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, DRD1, DRD2, DRD3, FABP3, FLT3, IGF1R, MMP2, PPARA, SRC, TYR |
2.1962 |
[BP] GO:0006936 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
2.18795 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, HCAR2, HTR1A, HTR2A, HTR2B, SRC |
2.18111 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, AURKB, AXL, CSNK2A1, DRD1, DRD2, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, PTPRS, SRC, TNKS, XDH |
2.14678 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.1438 |
[BP] GO:0001975 |
None
|
DRD1, DRD2, DRD3 |
2.1438 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, CA2, CYP1A1, CYP1A2, DRD2, FABP4, MMP9 |
2.13754 |
[BP] GO:0007623 |
circadian rhythm
|
DRD2, DRD3, HTR7, PPARA, RORC |
2.13683 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA1A, ALOX15, DRD1, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MMP9, PPARA, SRC, XDH |
2.10983 |
[BP] GO:0007189 |
None
|
ADRA1A, DRD1, DRD2, DRD3 |
2.10495 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.10362 |
[BP] GO:0030534 |
None
|
DRD1, DRD2, DRD3, HTR2A, PPARA |
2.08395 |
[BP] GO:0030335 |
positive regulation of cell migration
|
DRD1, F10, F3, IGF1R, KDR, MET, MMP9, SRC |
2.0813 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, DRD2, DRD3, HTR2A, MMP9 |
2.07673 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, AURKB, AXL, DRD2, DRD3, IGF1R, KDR, MET, MMP1, MMP9, SRC, TNKS, TNKS2 |
2.07673 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, HTR2B, IGF1R, KDR, MMP9, PIM1, SRC |
2.07673 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, DRD3 |
2.07673 |
[BP] GO:0014059 |
None
|
DRD2, DRD3, HTR2A |
2.07673 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.07673 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.07673 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.07673 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.07673 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.07673 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.07673 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B |
2.07673 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA1A, AXL, CA2, CYP1B1, DRD2, DRD3, F3, HCAR2, HTR2A, HTR2B, KDR, MET, MMP9, PIM1, SRC |
2.04096 |
[BP] GO:0060401 |
None
|
ADRA1A, DRD2, HTR2A, HTR2B |
2.04047 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, AXL, CA4, DRD1, DRD2, DRD3, F10, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PTPRS, SIGMAR1 |
6.38174 |
[CC] GO:0044459 |
plasma membrane part
|
ABCB1, ADORA1, ADORA3, ADRA1A, ALOX15, AXL, CA2, CA4, CA9, DRD1, DRD2, DRD3, F10, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PTPRS, SIGMAR1, SRC |
5.10069 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, AXL, DRD1, DRD2, DRD3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PTPRS, SIGMAR1 |
4.70358 |
[CC] GO:0016020 |
membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA1A, ALOX15, ALOX5, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, F10, F3, FLT3, HCAR2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, PIM1, PTPRS, SIGMAR1, SRC, TNKS, TNKS2, TYR |
4.59712 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA1A, ALOX15, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, DRD1, DRD2, DRD3, F10, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, PIM1, PTPRS, SRC |
4.39646 |
[CC] GO:0044425 |
membrane part
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA1A, ALOX15, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, F10, F3, FLT3, HCAR2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PTPRS, SIGMAR1, SRC, TYR |
3.50839 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.43459 |
[CC] GO:0098590 |
plasma membrane region
|
ABCB1, ADORA1, ADRA1A, CA2, CA4, CA9, DRD1, DRD2, HTR2A, MET, SIGMAR1, SRC |
2.17644 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
17.3081 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX15, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, F10, F3, FABP3, FABP4, FLT3, HSD17B1, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPRS, RORC, SRC, TNKS, TNKS2, TUBB3, TYR, XDH |
14.4225 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, MMP1, MMP2, MMP9, PIM1, PPARA, RORC, TNKS, TYR, XDH |
13.1235 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.0692 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
9.77861 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, ALPL, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, F10, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, MMP1, MMP2, MMP9, PIM1, PPARA, RORC, TNKS, TNKS2, TYR, XDH |
8.98098 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
8.43253 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
8.43253 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, ADORA1, AKR1B1, ALOX15, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, F10, F3, FLT3, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PTPRS, SRC, TNKS, TNKS2, TUBB3, TYR, XDH |
8.43253 |
[MF] GO:0008227 |
None
|
ADRA1A, DRD2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.81279 |
[MF] GO:0030594 |
None
|
DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.07832 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
7.04011 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, XDH |
6.99848 |
[MF] GO:0004993 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.99848 |
[MF] GO:0099589 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.99848 |
[MF] GO:0043176 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.97716 |
[MF] GO:0051378 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.97716 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, DRD1, DRD2, DRD3, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, RORC, SIGMAR1 |
6.85598 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6, DRD1, DRD2, DRD3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, PIM1, PPARA, SIGMAR1, SRC |
6.59776 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
6.58367 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TYR |
6.32282 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, DRD1, DRD2, DRD3, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
6.03824 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, DRD1, DRD2, DRD3, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
6.03824 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, DRD1, DRD2, DRD3, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, RORC, SIGMAR1 |
6.0081 |
[MF] GO:0099528 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
5.92996 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA1A, AXL, DRD1, DRD2, DRD3, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, RORC, SIGMAR1 |
5.81929 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
5.54857 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, SRC |
5.46193 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HSD17B1, HSD17B2, TYR, XDH |
5.40926 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA1A, AXL, DRD1, DRD2, DRD3, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, RORC, SIGMAR1 |
5.36722 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, SRC |
5.25183 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
5.22655 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TYR |
4.92805 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, MMP1, MMP2, MMP9, PPARA, RORC, TNKS |
4.90854 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
4.6719 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, ALPL, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, F10, MMP1, MMP2, MMP9, PIM1, PPARA, RORC, TNKS, TNKS2, TYR, XDH |
3.96214 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, ADRA1A, DRD1, DRD2, DRD3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
3.84724 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.50911 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HSD17B1, SRC, XDH |
3.24616 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.081 |
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3 |
3.01911 |
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3 |
2.92126 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.87875 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.50847 |
[MF] GO:1901338 |
None
|
DRD1, DRD2, DRD3 |
2.43459 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, CBR1, HSD17B1, HSD17B2, XDH |
2.13683 |
[MF] GO:0003676 |
nucleic acid binding
|
PPARA, RORC |
2.34591 |